BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28326594)

  • 1. Hypoacetylation of acetyl-histone H3 (H3K9ac) as marker of poor prognosis in oral cancer.
    Webber LP; Wagner VP; Curra M; Vargas PA; Meurer L; Carrard VC; Squarize CH; Castilho RM; Martins MD
    Histopathology; 2017 Aug; 71(2):278-286. PubMed ID: 28326594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
    Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
    Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel lncRNA LOLA1 may predict malignant progression and promote migration, invasion, and EMT of oral leukoplakia via the AKT/GSK-3β pathway.
    Liu W; Yao Y; Shi L; Tang G; Wu L
    J Cell Biochem; 2021 Oct; 122(10):1302-1312. PubMed ID: 33969929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma.
    Hu Y; He MY; Zhu LF; Yang CC; Zhou ML; Wang Q; Zhang W; Zheng YY; Wang DM; Xu ZQ; Wu YN; Liu LK
    J Exp Clin Cancer Res; 2016 Jan; 35():12. PubMed ID: 26769084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H3 and H3.3 histone mRNA amounts and ratio in oral squamous cell carcinoma and leukoplakia.
    Piscopo M; Campisi G; Colella G; Bilancione M; Caccamo S; Di Liberto C; Tartaro GP; Giovannelli L; Pulcrano G; Fucci L
    Oral Dis; 2006 Mar; 12(2):130-6. PubMed ID: 16476033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of histone H3 serine 10 phosphorylation and histone H4 lysine 12 acetylation in oral squamous cell carcinoma.
    Campos-Fernández E; Matsuo FS; Andrade MF; Servato JPS; Loyola AM; Cardoso SV; Siva SJ; Moraes ADS; de Faria PR
    Histopathology; 2019 Jan; 74(2):227-238. PubMed ID: 30007038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical location of the p75 neurotrophin receptor (p75NTR) in oral leukoplakia and oral squamous cell carcinoma.
    Kiyosue T; Kawano S; Matsubara R; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
    Int J Clin Oncol; 2013 Feb; 18(1):154-63. PubMed ID: 22170235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast Growth Factor (FGF-2) and Its Receptors FGFR-2 and FGFR-3 May Be Putative Biomarkers of Malignant Transformation of Potentially Malignant Oral Lesions into Oral Squamous Cell Carcinoma.
    Nayak S; Goel MM; Makker A; Bhatia V; Chandra S; Kumar S; Agarwal SP
    PLoS One; 2015; 10(10):e0138801. PubMed ID: 26465941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis.
    Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO
    Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential roles of kallikrein-related peptidase 6 in malignant transformation and ΔNp63β-mediated epithelial-mesenchymal transition of oral squamous cell carcinoma.
    Kaneko N; Kawano S; Yasuda K; Hashiguchi Y; Sakamoto T; Matsubara R; Goto Y; Jinno T; Maruse Y; Morioka M; Hattori T; Tanaka S; Tanaka H; Kiyoshima T; Nakamura S
    Oral Oncol; 2017 Dec; 75():148-157. PubMed ID: 29224812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
    Sutariya RV; Manjunatha BS
    J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The methylation status and expression of human telomerase reverse transcriptase is significantly high in oral carcinogenesis.
    Haraguchi K; Yada N; Sato S; Habu M; Hayakawa M; Takahashi O; Sasaguri M; Takenaka S; Yoshioka I; Matsuo K; Tominaga K
    APMIS; 2017 Sep; 125(9):797-807. PubMed ID: 28766760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of GDF10/BMP3b as a prognostic marker collaborates with TGFBR3 to enhance chemotherapy resistance and epithelial-mesenchymal transition in oral squamous cell carcinoma.
    Cheng CW; Hsiao JR; Fan CC; Lo YK; Tzen CY; Wu LW; Fang WY; Cheng AJ; Chen CH; Chang IS; Jiang SS; Chang JY; Lee AY
    Mol Carcinog; 2016 May; 55(5):499-513. PubMed ID: 25728212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma--an immunohistochemical study.
    Gupta K; Metgud R; Gupta J
    J Cancer Res Ther; 2015; 11(4):893-8. PubMed ID: 26881537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of ATAD2 indicates Poor Prognosis in Oral Squamous Cell Carcinoma.
    Wang XL; Wang S; Wu ZZ; Yang QC; Li H; Xiong HG; Wan SC; Sun ZJ
    Int J Med Sci; 2020; 17(11):1598-1609. PubMed ID: 32669963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of H3K9ac and H4K12ac With Cell Proliferation Marker Ki-67 in Oral Leukoplakia: An Immunohistochemical Study.
    Espinosa RCG; Costa ARGF; Garcia Júnior MA; Ribeiro RIMA; Cardoso SV; de Faria PR; Loyola AM
    Appl Immunohistochem Mol Morphol; 2022 Sep; 30(8):566-572. PubMed ID: 35960013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTEN allelic loss is an important mechanism in the late stage of development of oral leucoplakia into oral squamous cell carcinoma.
    Miyahara LAN; Pontes FSC; Burbano RMR; Conte Neto N; Guimarães DM; Fonseca FP; Pontes HAR
    Histopathology; 2018 Jan; 72(2):330-338. PubMed ID: 28858374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of FAM3C is associated with poor prognosis in oral squamous cell carcinoma.
    Wu CC; Xiao Y; Li H; Mao L; Deng WW; Yu GT; Zhang WF; Sun ZJ
    Pathol Res Pract; 2019 Apr; 215(4):772-778. PubMed ID: 30683473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.